Bio synthesis, Characterization of ZnO Nanoparticles from Scoparia dulcis L. plant extract and its in-vitro Antioxidant, Acetylcholinesterase Activity

The current investigation is focused on the use of green synthesis methods for zinc oxide nanoparticles (ZnO NPs) from Scoparia dulcis L. extract (SDE). SDE-mediated ZnO NPs (SDE-ZnO-NPs) were made using a simple and eco-friendly method that required little reaction time and calcinations temperature. UV-Vis, FTIR, X-ray powder diffraction, SEM, TEM & EDAX were used into characterizes the skeletal and synthetic properties concerning biosynthesized ZnO nonmaterial. The UV–Visible spectroscopy absorption peak for SDE-ZnO-NPs was found to be at 380 nm, confirming the production of ZnO NPs. The FTIR spectrum also revealed bioactive functional groups as well as metal-oxygen groups. Synthesized ZnO NPs had a rod shape in 200 nm, according to TEM examination. The Zn and O in the produced ZnO NPs were approved by the EDAX analysis. The XRD results revealed that it had a crystal structure that was similar to SDE-ZnO-NPs. The dose-related Acetylcholinesterase inhibitory action of SDE-ZnO NPs was determined utilizing the Ellman’s test. AChE activity of the synthesized nanoparticles showed potential inhibitory activity with IC50 values of 75.34 µg/mL. The antioxidant activity was investigated the biosynthesized ZnO-NPs using DPPH, ABTS assay

Antidandruff activity of Cassia auriculata and Cassia alata through fatty acids mediated inhibition of Malassezia furfur

Susceptibility of Malassezia furfur to certain medium chain fatty acids shed light onto novel strategies to control dandruff. This study explored antidandruff activity of the fatty acids and other bioactive compounds from flowers of Cassia auriculata and Cassia alata. The idea was supplementing the growth medium with fatty acids which are inhibitory to Malassezia so that plant-based antidandruff formulations could be developed based on the results. Chloroform and ethanolic flower extracts were tested there in vitro efficacy against M. furfur and the potential antidandruff compounds were identified by gas chromatography-mass spectrophotometry (GC-MS). Minimum inhibitory concentrations were determined for both the extracts and IC50 values of 50 and 88 µM for chloroform extract of C. auriculata and C. alata were recorded. For ethanol extract, IC50 values of 75 and 70 µM were exhibited by C. auriculata and C. alata, respectively. Inhibition of M. furfur through fatty acids from Cassia is the first report, and it is possible to include specific fatty acids in the growth media to inhibit the growth of Malassezia which could be later served as lead molecules in antidandruff formulations. Further, the presence of citronellol, pinitol, anthracenedione and chrysine in Cassia flower extracts and their antidandruff activity reported in this study needed further research on those compounds to formulate effective treatment of Malassezia associated diseases

A microarray gene expression data classification using hybrid back propagation neural network

Classification of cancer establishes appropriate treatment and helps to decide the diagnosis. Cancer expands progressively from an alteration in a cell's genetic structure. This change (mutation) results in cells with uncontrolled growth patterns. In cancer classification, the approach, Back propagation is sufficient and also it is a universal technique of training artificial neural networks. It is also called supervised learning method. It needs many dataset for input and output for making up the training set. The back propagation method may execute the function of collaborate multiple parties. In existing method, collaborative learning is limited and it considers only two parties. The proposed collaborative function can perform well and problems can be solved by utilizing the power of cloud computing. This technical note applies hybrid models of Back Propagation Neural networks (BPN) and fast Genetic Algorithms (GA) to estimate the feature selection in gene expression data. The proposed research work examines many feature selection algorithms which are “fragile”; that is, the superiority of their results varies broadly over data sets. By this research, it is suggested that this is due to higherorder interactions between features causing restricted minima in search space in which the algorithm becomes attentive. GAs may escape from such minima by chance, because works are highly stochastic. A neural net classifier with a genetic algorithm, using the GA to select features for classification by the neural net and incorporating the net as part of the objective function of the GA

Development and Evaluation of a Chloramphenicol Hypertonic Ophthalmic Solution

Hypertonic ophthalmic solutions are used to treat ocular diseases associated with edema. In this study, we developed a chloramphenicol hypertonic ophthalmic solution. These drops were developed based on the cosolvency and additional dielectric constant concepts. Two different solvents: PEG 300 and glycerol were used as cosolvents. Solubility curves were plotted. Based on the solubility curves, two different solutions were selected. These solutions were evaluated for physical parameters and accelerated stability. The results indicated that chloramphenicol was stable in these formulations. The selected blend of solutions was hypertonic. Thus, the solubility and stability of chloramphenicol was enhanced using a cosolvency technique so as to develop a chloramphenicol hypertonic ophthalmic solution

Novel ion exchange resin-based combination drug-delivery system for treatment of gastro esophageal reflux diseases

The present study involves preparation and characterization of a combination tablet of ranitidine in immediate release form and domperidone in sustained release form, using ion exchange resins. Ranitidine lowers acid secretion, while domperidone release over a prolonged period improves gastric motility thus justifying this combination in gastro esophageal reflux diseases (GERD) and ensuring patient compliance. Drug loading was carried out by batch method & resinates were characterized using FTIR, XRPD. Resinates were formulated as a combination tablet and evaluated for tablet properties & in vitro drug release. Resinates provided sustained release of domperidone and immediate release of ranitidine. IR and X-ray studies indicate complexation of drug and resin along with monomolecular distribution of drugs in amorphous form in the resin matrix. The tablets of resinate combination showed good tablet properties. In-vitro drug release gave desired release profiles and ex-vivo drug absorption studies carried out by placing everted rat intestine in dissolution medium indicated statistically significant similarity in absorption from test and marketed formulation. The novelty of this study is that the retardation in release of domperidone from resinates is achieved by presence of weak resin in the formulation.<br>O presente estudo envolve a preparação e a caracterização de associação do comprimido de ranitidina de liberação imediata e domperidona de liberação prolongada, utilizando resinas de troca iônica. A ranitidina diminui a secreção ácida, enquanto a liberação prolongada de domperidona melhora a motilidade gástica, justificando, dessa forma, a associação em doenças de refluxo gastroesofágico (DRGE) e garantindo a adesão do paciente. A carga de fármaco foi efetuada pelo método em batelada e os resinatos, caracterizados utilizando-se FTIR e XRPD. Os resinatos foram formulados como comprimido da associação e avaliados com relação às propriedades dos comprimidos e liberação do fármaco in vitro. Os resinatos proporcionaram a liberação prolongada da domperidona e a liberação imediata da ranitidina. IV e estudos de difração de raios X indicaram a complexação do fármaco e da resina junto com a distribuição monomolecular dos fármacos, em estado amorfo, na matriz da resina. Os comprimidos da associação do resinato apresentaram boas propriedades. Obtiveram-se os perfis de liberação in vitro e os estudos de absorção dos fármacos ex vivo realizados com intestino de rato em meio de dissolução indicaram semelhança significativa na absorção entre as formulações teste e comercializada. A inovação do trabalho é que o retardamento da liberação da domperidona dos resinatos é atingido pela presença de resina fraca na formulação